Summit Partners Public Asset Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Summit Partners Public Asset Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-21,593	Closed	-$6M	–	144
2022 Q3	$6M	Buy	21,593 +438	+2%	+$111K	0.31%	78
2022 Q2	$4.04M	Sell	21,155 -32,689	-61%	-$5.77M	0.18%	96
2022 Q1	$11.2M	Buy	+53,844	New	+$8.88M	0.4%	71

Other funds holding SWAV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Summit Partners Public Asset Management's SWAV Position: Q4 2022 in Review

Summit Partners Public Asset Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2022, closing a stake of 21,593 shares — an estimated $6M sold.

Summit Partners Public Asset Management first reported a position in SWAV in Q1 2022 and held it in 3 quarters. The position peaked at $11.2M in Q1 2022. 415 funds tracked by Wall St. Rank hold SWAV as of Q4 2022.

Summit Partners Public Asset Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Summit Partners Public Asset Management sold 21,593 Shockwave Medical, Inc. Common Stock shares in Q4 2022, an estimated $6M.
Summit Partners Public Asset Management first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
Summit Partners Public Asset Management's Shockwave Medical, Inc. Common Stock position peaked at $11.2M in Q1 2022.
415 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2022.

Based on Summit Partners Public Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.